Digital Therapeutics

Selected news for the healthcare topic - Digital Therapeutics, collected since 10/2017. This healthcare topic shares news with Digital Health, Mental Health, DarioHealth, Pear Therapeutics, COVID-19 and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/11/2022 Time is running out to apply to pitch your healthcare startup at MedCity INVEST - MedCity News MedCity News ... the board, Big Pharma is looking to go beyond the pill. Startups in this category are using digital tools to help every aspect of the pharmaceutical industry, be it drug development, clinical trials, manufacturing, digital therapeutics , patient engagement and more.Diagnostics 2.0Convenience is the name of the game especially after the pandemic when it comes to the world of diagnostics. Startups in this category are developing either at-home ...
1/11/2022 AliveCor Announces Strategic Additions to Executive Team PR Newswire ... and has led three acquisitions, two IPOs, and numerous venture rounds. He previously served as Vice President of Sales overseeing the Marketing Cloud Payor business at Salesforce and has held leadership roles in telehealth, digital therapeutics , and health at Cisco, IBM, Avizia (acquired by AmWell), and Propeller Health (acquired by Resmed). Balsamo joins AliveCor from a Sequoia-backed stealth AI company, where he served as Chief Revenue Officer and interim ...
1/11/2022 AliveCor Announces Strategic Additions to Executive Team PR Newswire ... and has led three acquisitions, two IPOs, and numerous venture rounds. He previously served as Vice President of Sales overseeing the Marketing Cloud Payor business at Salesforce and has held leadership roles in telehealth, digital therapeutics , and health at Cisco, IBM, Avizia (acquired by AmWell), and Propeller Health (acquired by Resmed). Balsamo joins AliveCor from a Sequoia-backed stealth AI company, where he served as Chief Revenue Officer and interim ...
1/10/2022 Neurology Digital Therapeutics Market is anticipated to witness a 9.0% growth during the forecast period from 2021 to 2031 globalbankingandfinance.com Neurology digital therapeutics is the field of healthcare that deals with and prevents medical conditions using information and communication technology. According to the recent research by FMI, the Neurology Digital Therapeutics Market is anticipated to witness a 9.0% growth during the forecast period from 2021 to 2031. This significant growth will be experienced due to the advancement in technology in the healthcare sector. Therefore, neurology digital therapeutics demand is expected ...
1/10/2022 2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again? newsnationusa.com ... to a rumor reported by Bloomberg. Social Capital Suvretta Holdings Corp 1 (NASDAQ: DNAA ) is nearing a deal with Akili Interactive that could value the prescription digital medicine company at $800 million.Akili offers digital therapeutics using “captivating action video-game experiences.” Digital therapeutics have been shows to improve attention from children who suffer from attention-deficit hyperactivity disorder, according to the report.Akili is targeting treatments for autism ...
1/9/2022 2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again? | Markets Insider Business Insider ... to a rumor reported by Bloomberg. Social Capital Suvretta Holdings Corp 1 (NASDAQ: DNAA ) is nearing a deal with Akili Interactive that could value the prescription digital medicine company at $800 million.Akili offers digital therapeutics using “captivating action video-game experiences.” Digital therapeutics have been shows to improve attention from children who suffer from attention-deficit hyperactivity disorder, according to the report.Akili is targeting treatments for autism ...
1/8/2022 Use this app and call me in the morning: The promise of prescription digital therapeutics Seeking Alpha Use this app and call me in the morning: The promise of prescription digital therapeuticsJan. 08, 2022 1:49 PM ET Better Therapeutics, Inc. (BTTX) , PEAR [DNAA](/symbol/DNAA?source=content_type%3Areact%7Csection ...
1/8/2022 Digital Therapeutics Market worth USD 13.1 billion by 2026 : Patient convenience and user-friendliness emailwire.com ... 08, 2022 ) The Growth in this DTx market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics . On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.According ...
1/8/2022 Sensyne Health (OTCMKTS:SSYNF) Trading Up 2.9% - American Banking News American Banking News ... Company Profile ( OTCMKTS:SSYNF )Sensyne Health Plc is a healthcare technology company, which engages in the discovery and development of new medicines. It also develop clinically validated software applications by artificial intelligence comprises prescribed digital therapeutics and hospital systems. Its products include SEND, GDm-Health, CVm-Health, DBm-Health, CleanSpace, and EDGE.Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary ...
1/8/2022 Sensyne Health (OTCMKTS:SSYNF) Trading Up 2.9% - Slater Sentinel slatersentinel.com ... Company Profile ( OTCMKTS:SSYNF )Sensyne Health Plc is a healthcare technology company, which engages in the discovery and development of new medicines. It also develop clinically validated software applications by artificial intelligence comprises prescribed digital therapeutics and hospital systems. Its products include SEND, GDm-Health, CVm-Health, DBm-Health, CleanSpace, and EDGE.Recommended Story: Learning About the VIX – Volatility Index ...
1/7/2022 Why providers are key to digital therapeutic uptake MobiHealthNews ... getting drug therapies,” Celeste James, vice president of equity and population health at Big Health , said during a panel at CES. “And so what I see is that more and more we're seeing digital therapeutics companies entering the market to enable access.”The COVID-19 pandemic, which accelerated the use of telehealth as providers and patients sought to remain distant, galvanized digital therapeutics too. But with the wider ...
1/5/2022 KT Corp. partners with Catholic Medical Center to develop new DTx MobiHealthNews ... with the Catholic Medical Center of the Catholic University of Korea to jointly develop digital treatment devices.WHAT IT'S ABOUTUnder the agreement, the companies will jointly cooperate to develop a platform to create digital therapeutics (DTx) devices and build prototypes. They will also hold an idea contest for digital treatment devices.On its end, KT Corp. said it plans to combine AI, big data, and cloud technologies with DTx ...
1/5/2022 Ep. 17: A Continuation Into the Role of Digital Therapeutics in Healthcare – Jennifer Ginest and Chris Wasden of Happify Health pharma-mkting.com Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN, discuss the current role of Digital Therapeutics in Healthcare and were it is headed ...
1/4/2022 TD Ameritrade Network | DarioHealth (DRIO) CEO On Digital Therapeutic Solutions tdameritradenetwork.com ... 4% in the last 5 days. The company offers digital therapeutic solutions to customers. This covers multiple chronic conditions including diabetes, hypertension, and behavioral health. CEO Dr. Erez Raphael weighs in on telehealth versus digital therapeutics . Also, he covers the growth strategy for 2022.04 Jan 2022Trading 36025 Oct 2021The Watch List12 Oct 2021The Watch List22 Oct 2021Market On Close01 Dec 2021 ...
1/4/2022 Global Pharmaceutical Industry Growth Opportunities 2022: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity - ResearchAndMarkets.com Yahoo News ... stage drugs and novel technologies has led to a higher rate of licensing and mergers with small biopharma that are developing the same. In addition, patient engagement has been driving digital partnerships centred around digital therapeutics , decentralized clinical trials, remote monitoring, and telemedicine.The study also provides critical insights into the key regulatory, reimbursement, and policy updates for 2021, ranging from health data standardization and quality regulation to direct drug ...
1/4/2022 Global Pharmaceutical Industry Growth Opportunities 2022: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity - ResearchAndMarkets.com | Business Wire Business Wire ... stage drugs and novel technologies has led to a higher rate of licensing and mergers with small biopharma that are developing the same. In addition, patient engagement has been driving digital partnerships centred around digital therapeutics , decentralized clinical trials, remote monitoring, and telemedicine.The study also provides critical insights into the key regulatory, reimbursement, and policy updates for 2021, ranging from health data standardization and quality regulation to direct drug ...
1/4/2022 Global Pharmaceutical Industry Growth Opportunities 2022: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity - ResearchAndMarkets.com | Business | dailyrecordnews.com dailyrecordnews.com ... stage drugs and novel technologies has led to a higher rate of licensing and mergers with small biopharma that are developing the same. In addition, patient engagement has been driving digital partnerships centred around digital therapeutics , decentralized clinical trials, remote monitoring, and telemedicine.The study also provides critical insights into the key regulatory, reimbursement, and policy updates for 2021, ranging from health data standardization and quality regulation to direct drug ...
1/4/2022 Global Pharmaceutical Industry Growth Opportunities 2022: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity - ResearchAndMarkets.com | Business | The Daily News galvnews.com ... stage drugs and novel technologies has led to a higher rate of licensing and mergers with small biopharma that are developing the same. In addition, patient engagement has been driving digital partnerships centred around digital therapeutics , decentralized clinical trials, remote monitoring, and telemedicine.The study also provides critical insights into the key regulatory, reimbursement, and policy updates for 2021, ranging from health data standardization and quality regulation to direct drug ...
1/4/2022 Global Digital Therapeutics Market to Reach $12.1 Billion by 2026 PR Newswire ... the premier market research company, today released its report titled "Digital Therapeutics - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.Global Digital Therapeutics Market FACTS AT A GLANCE Edition: 8; Released: December 2021 Executive Pool: 6352 Companies: 108 - Players covered include Canary Health, Inc.; Dthera Sciences; Fitbit Health Solutions; Livongo Health, Inc.; Medtronic, Plc; Omada Health, Inc ...
1/4/2022 Global Digital Therapeutics Market to Reach $12.1 Billion by 2026 Yahoo News ... the premier market research company, today released its report titled "Digital Therapeutics - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.Global Digital Therapeutics Market FACTS AT A GLANCEEdition: 8; Released: December 2021Executive Pool: 6352Companies: 108 - Players covered include Canary Health, Inc.; Dthera Sciences; Fitbit Health Solutions; Livongo Health, Inc.; Medtronic, Plc; Omada Health, Inc ...